Poor Myelin Repair Offers Clues in Disease Progression & ECTRIMS and Other MS News
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads about a study that shows how new myelin production may be less efficient in late-onset multiple sclerosis patients, which could underlie more severe disease progression.
He also reads “MS News That Caught My Eye Last Week: ECTRIMS, Ocrevus, Kesimpta, Epstein-Barr, DMTs” by Ed Tobias, from his column “The MS Wire”.
==...
13m
•
Nov 09, 2022